TAM
INO icon

Tocqueville Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Tocqueville Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-667
Closed -$216K – 664
2020
Q2 		$216K Sell
667
-1,541
-70% -$247K ﹤0.01% 618
2020
Q1 		$197K Sell
2,208
-1,650
-43% -$102K ﹤0.01% 598
2019
Q4 		$153K Sell
3,858
-834
-18% -$25.1K ﹤0.01% 711
2019
Q3 		$115K Sell
4,692
-1,333
-22% -$40.5K ﹤0.01% 737
2019
Q2 		$213K Buy
6,025
+1,000
+20% +$39.7K ﹤0.01% 734
2019
Q1 		$225K Buy
+5,025
New +$253K ﹤0.01% 716
2018
Q3 		– Sell
-2,458
Closed -$116K – 836
2018
Q2 		$116K Hold
2,458
– – ﹤0.01% 807
2018
Q1 		$139K Sell
2,458
-1,950
-44% -$106K ﹤0.01% 805
2017
Q4 		$218K Buy
+4,408
New +$273K ﹤0.01% 750
2017
Q1 		– Sell
-1,750
Closed -$146K – 817
2016
Q4 		$146K Sell
1,750
-542
-24% -$49K ﹤0.01% 772
2016
Q3 		$256K Sell
2,292
-3,675
-62% -$406K ﹤0.01% 736
2016
Q2 		$662K Buy
5,967
+100
+2% +$12.1K 0.01% 577
2016
Q1 		$613K Buy
5,867
+217
+4% +$16.8K 0.01% 590
2015
Q4 		$456K Buy
5,650
+1,292
+30% +$103K 0.01% 682
2015
Q3 		$302K Sell
4,358
-292
-6% -$25.4K ﹤0.01% 805
2015
Q2 		$455K Buy
4,650
+1,233
+36% +$132K 0.01% 740
2015
Q1 		$335K Sell
3,417
-416
-11% -$40.3K ﹤0.01% 787
2014
Q4 		$422K Sell
3,833
-917
-19% -$112K ﹤0.01% 739
2014
Q3 		$561K Buy
4,750
+3,052
+180% +$380K 0.01% 592
2014
Q2 		$220K Hold
1,698
– – ﹤0.01% 945
2014
Q1 		$271K Buy
+1,698
New +$244K ﹤0.01% 726

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Tocqueville Asset Management's INO Position: Q3 2020 in Review

Tocqueville Asset Management sold out of Inovio Pharmaceuticals (INO) in Q3 2020, closing a stake of 667 shares — an estimated $216K sold.

Tocqueville Asset Management first reported a position in INO in Q1 2014 and held it in 21 quarters. The position peaked at $662K in Q2 2016. 212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

  • Tocqueville Asset Management reported no remaining Inovio Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Tocqueville Asset Management sold 667 Inovio Pharmaceuticals shares in Q3 2020, an estimated $216K.
  • Tocqueville Asset Management first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 21 quarters.
  • Tocqueville Asset Management's Inovio Pharmaceuticals position peaked at $662K in Q2 2016.
  • 212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.